Not exact matches
In 2010, researchers from the University of Michigan Comprehensive
Cancer Center published a study in the journal Clinical Cancer Research showing that sulforaphane had the ability to kill breast cancer stem cells in mice and in lab cultures, and it also prevented the growth of new tumor
Cancer Center published a study in the journal Clinical
Cancer Research showing that sulforaphane had the ability to kill breast cancer stem cells in mice and in lab cultures, and it also prevented the growth of new tumor
Cancer Research showing that sulforaphane had the ability to kill breast
cancer stem cells in mice and in lab cultures, and it also prevented the growth of new tumor
cancer stem cells in mice and in lab cultures, and it also prevented the growth of new tumor cells.
Dr. Greenbaum and Dr. Łksza also played an integral role in a companion piece of
research led by researchers Vinod P. Balachandran, MD, Taha Merghoub, PhD, and Steven D. Leach, MD, at Memorial Sloan Kettering
Cancer Center (MSK) that was also
published in Nature today.
This is the main finding of new
research led by investigators at NYU Langone Medical
Center and its Perlmutter
Cancer Center and
published online May 19 in the Journal of the National
Cancer Institute.
Center for Nuclear Receptors & Cell Signaling (CNRCS) Assistant Professor Daniel Frigo and his
research team recently
published a study investigating the processes through which androgen receptors affect prostate
cancer progression.
Jean - Pierre Issa, MD, Director of the Fels Institute for
Cancer Research and Molecular Biology at Temple University School of Medicine and co-Leader of the
Cancer Epigenetics Program at the Fox Chase
Cancer Center is lead author of the study, which has been
published August 19 in the journal, Lancet Oncology.
Networks or not, doctors and health officials also have to decide how to treat patients based on
published research that could be overturned, notes oncologist Benjamin Djulbegovic of the H. Lee Moffitt Cancer Center and Research Institute i
research that could be overturned, notes oncologist Benjamin Djulbegovic of the H. Lee Moffitt
Cancer Center and
Research Institute i
Research Institute in Tampa.
Now, a new study led by infectious disease researcher Dr. Sachiko Seo, formerly of Fred Hutch and now a physician at the National
Cancer Research Center East in Chiba, Japan, and Boeckh and
published last month in the journal Haematologica has found that like more «serious» viruses, rhinovirus can cause pneumonia — and when it does, it can be deadly to those recovering from transplantation.
The results of the study were
published this week in the journal Nature Medicine from researchers at Penn's Abramson
Cancer Center, including senior author Carl H. June, MD, the Richard W. Vague Professor in Immunotherapy in the department of Pathology and Laboratory Medicine and director of Translational
Research in the ACC, the University of Maryland School of Medicine, and Adaptimmune Therapeutics plc (Adaptimmune).
For instance, a finding
published by researchers at the Pennington Biomedical
Research Center in Baton Rouge, Louisiana, in 2009 said that longer lengths of sitting were directly proportional to an increased risk of death from cardiovascular disease and most causes of death other than
cancer.
A University of Colorado
Cancer Center study published in the journal Breast Cancer Research and Treatment shows that breast cancer patients whose health insurance plans included prescription drug benefits were 10 percent more likely to start important hormonal therapy than patients who did not have prescription drug cov
Cancer Center study
published in the journal Breast
Cancer Research and Treatment shows that breast cancer patients whose health insurance plans included prescription drug benefits were 10 percent more likely to start important hormonal therapy than patients who did not have prescription drug cov
Cancer Research and Treatment shows that breast
cancer patients whose health insurance plans included prescription drug benefits were 10 percent more likely to start important hormonal therapy than patients who did not have prescription drug cov
cancer patients whose health insurance plans included prescription drug benefits were 10 percent more likely to start important hormonal therapy than patients who did not have prescription drug coverage.
Seemingly healthy cells may in fact hide clues that lung
cancer will later develop, according to a study led by researchers at The University of Texas MD Anderson Cancer Center The research is published online in the Journal of the National Cancer Inst
cancer will later develop, according to a study led by researchers at The University of Texas MD Anderson
Cancer Center The research is published online in the Journal of the National Cancer Inst
Cancer Center The
research is
published online in the Journal of the National
Cancer Inst
Cancer Institute.
The study,
published in PLOS Medicine, was led by Wei Zheng, M.D., Ph.D., MPH, professor of Medicine and director of the Vanderbilt Epidemiology
Center, and John Potter, M.D., Ph.D., a member and scientific advisor of the Fred Hutchinson
Cancer Research Center, Seattle, Washington.
A University of Colorado
Cancer Center study recently
published in the top - ranked journal Nucleic Acids
Research (NAR) describes a database named multiMiR, the most comprehensive database collecting information about microRNAs and their targets.
In their report
published in
Cancer Immunology
Research, a team from the Vaccine and Immunotherapy
Center (VIC) at Massachusetts General Hospital (MGH) describes how adding AMD3100 (plerixafor)-- previously approved for the stimulation of stem cell production prior to bone marrow transplantation — to their investigational drug VIC - 008 more than doubled the animals» survival time.
According to a new «proof of principle» study
published in Aug. 27 issue of
Cancer Prevention Research, Moffitt Cancer Center researchers hope to improve pancreatic cancer survival rates by identifying markers in the blood that can pinpoint patients with premalignant pancreatic lesions called intraductal papillary mucinous neoplasms (I
Cancer Prevention
Research, Moffitt
Cancer Center researchers hope to improve pancreatic cancer survival rates by identifying markers in the blood that can pinpoint patients with premalignant pancreatic lesions called intraductal papillary mucinous neoplasms (I
Cancer Center researchers hope to improve pancreatic
cancer survival rates by identifying markers in the blood that can pinpoint patients with premalignant pancreatic lesions called intraductal papillary mucinous neoplasms (I
cancer survival rates by identifying markers in the blood that can pinpoint patients with premalignant pancreatic lesions called intraductal papillary mucinous neoplasms (IPMNs).
Family history of breast
cancer continues to significantly increase chances of developing invasive breast tumors in women ages 65 and older, according to research published by a team led by Dejana Braithwaite, PhD, associate professor of oncology at Georgetown University School of Medicine and a member of Georgetown Lombardi Comprehensive Cancer C
cancer continues to significantly increase chances of developing invasive breast tumors in women ages 65 and older, according to
research published by a team led by Dejana Braithwaite, PhD, associate professor of oncology at Georgetown University School of Medicine and a member of Georgetown Lombardi Comprehensive
Cancer C
Cancer Center.
Scientists from the German
Cancer Research Center (DKFZ) have now
published their results from an analysis of data pooled from more than half a million individuals across Europe and the US.
This study,
published in Nature Medicine, tested a novel CAR that was developed in the Mackall laboratory at the National
Cancer Institute (NCI) in a first - in - human, first - in - child study conducted by Drs. Fry, Shah, and colleagues in the NCI
Center for
Cancer Research's Pediatric Oncology Branch at the NIH Clinical
Center.
In a paper
published August 30 in Nature Communications, Dr. Matthias Stephan at Fred Hutchinson
Cancer Research Center describes nanoparticles he has developed that can streamline the delivery of bundled genetic material to specific cells.
Results of the international trial, led by principal investigator Jeffrey S. Weber, MD, PhD, the Laura and Isaac Perlmutter Professor of Oncology, deputy director of Perlmutter
Cancer Center, and co-leader of its Melanoma
Research Program, were
published in November 2017 in The New England Journal of Medicine.
Antibodies to a high - risk type of human papillomavirus (HPV16) could help detect oropharyngeal (1)
cancer several years before the clinical onset of the disease, reveals a new study from the International Agency for Research on Cancer (IARC) in cooperation with the German Cancer Research Center (DKFZ) and the United States National Cancer Institute (NCI) in an article published online today by the Journal of Clinical Onc
cancer several years before the clinical onset of the disease, reveals a new study from the International Agency for
Research on
Cancer (IARC) in cooperation with the German Cancer Research Center (DKFZ) and the United States National Cancer Institute (NCI) in an article published online today by the Journal of Clinical Onc
Cancer (IARC) in cooperation with the German
Cancer Research Center (DKFZ) and the United States National Cancer Institute (NCI) in an article published online today by the Journal of Clinical Onc
Cancer Research Center (DKFZ) and the United States National
Cancer Institute (NCI) in an article published online today by the Journal of Clinical Onc
Cancer Institute (NCI) in an article
published online today by the Journal of Clinical Oncology.
Several recent studies show the potential antidepressant properties of turmeric, according to Michelle Smekens, ND, FABO, naturopathic oncology provider at
Cancer Treatment Centers of America at Midwestern Regional Medical
Center, including one 2014 study
published in Psychotherapy
Research.
According to a detailed report
published by the the
Center For Science In The Public Interest there is significant
research linking these artificial food dyes to
cancer risk and many other harmful health conditions.
A
research team from the University of Colorado
Cancer Center have published the results of a study in the journal, Cancer Letters demonstrating that the more advanced colorectal cancer cells are, the more GSE inhibits their growth and sur
Cancer Center have
published the results of a study in the journal,
Cancer Letters demonstrating that the more advanced colorectal cancer cells are, the more GSE inhibits their growth and sur
Cancer Letters demonstrating that the more advanced colorectal
cancer cells are, the more GSE inhibits their growth and sur
cancer cells are, the more GSE inhibits their growth and survival.
TwoFoot Words 202design United Methodist
Publishing House United Nations United States Naval Institute University of Akron Press University of Alabama Press University of Alberta Press University of Arizona Press G&A University of Arizona Main Library University of Arkansas Press University of British Columbia Press University of California University of Chicago Press University of Georgia Press University of Illinois Press University of Maastricht University of Maine University of Michigan Press University of Missouri Press University of Nebraska Press University of Nevada Press University of New Mexico Press University of New South Wales Press University of North Carolina Press University of Notre Dame University of Oklahoma Press University of Otago Department of English University of Pittsburgh Press University of Pretoria University of Tennessee Press University of Texas, Applied
Research University of Texas Press University of Toronto Press University of Utah Press University of Victoria University of Virginia Press University of Wisconsin Press University Press of Kansas University Press of Kentucky U.S. Census Bureau U.S. Conference of Catholic Bishops U.S. Department of State U.S. Naval Institute Vanderbilt University Press Vectra Media VCU Massey
Cancer Center VES Andover Ltd Victorian Secrets Limited Village Typographers, Inc..
A just
published study by researchers at Fred Hutchinson
Cancer Research Center finds that obesity, alcohol use and smoking all significantly increase the risk of second breast cancer among breast cancer surv
Cancer Research Center finds that obesity, alcohol use and smoking all significantly increase the risk of second breast
cancer among breast cancer surv
cancer among breast
cancer surv
cancer survivors.